Skip to main content
OpenTrials
Completed

NCT Number: NCT04098172

Evaluate the Performance and Safety of Comet Pressure Guidewire in the Measurement of FFR

A prospective, open-label, multi-center study designed to validate the agreement of CometTM Pressure Guidewire and Pressure Wire Certus® in FFR measurements

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–75 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

The First Affilited Hospital of Xi,an Jiaotong University, Xi'an, Shaanxi, China

Loading trial locations.

About this study

The COMET China study is a prospective, open-label, multi-center study designed to validate the agreement of CometTM Pressure Guidewire and Pressure Wire Certus® in FFR measurements. Patient with stable angina or any form of non-ST elevation acute coronary syndrome, who are scheduled for diagnostic angiography and pressure wire assessment, and signed the informed consent, will be screened for enrollment in this study.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

General Inclusion Criteria:

  • Patient must be at least 18 years old and less than or equal to 75 years of age
  • Patient or his/her legally-authorized representative agrees to sign the EC-approved ICF prior to the procedure
  • Patient with stable angina or any form of non-ST elevation acute coronary syndrome and is clinically indicated of intra-coronary diagnostic angiography and FFR assessment

Angiographic Inclusion Criteria:

Moderate stenosis (30% to 70% diameter stenosis by visual estimation) is detected at diagnostic angiography

General Exclusion Criteria:

  • Patients unable to provide informed consent
  • Patients in pregnant state
  • Known renal insufficiency or failure (serum creatinine level of > 2.5 mg/dL, or on dialysis)
  • Allergy to the contrast
  • Significant arrhythmia, such as II degree or above of atrioventricular block, Sick sinus syndrome, ventricular tachycardia
  • Spastic bronchial asthma
  • ST elevation coronary syndrome
  • Hemodynamic instability
  • Contraindication to nitroglycerin or ATP
  • Current participation in another investigational drug or device clinical study that may affect the FFR measurements

Angiographic Exclusion Criteria:

CTO lesion Severe vessel tortuosity at the stenotic segments Culprit vessel of non-ST-segment elevation acute myocardial infarction

Treatment and study plan

Pressure Guidewire

Device

Fractional Flow Reserve measurement

Primary outcomes

  1. Fractional Flow Reserve (FFR)

    Time frame: during procedure, 1 hour

    All eligible subjects will receive FFR measurements simultaneously by both CometTM Pressure Guidewire and Pressure wires Certus®. Fractional flow reserve (FFR) measurement involves determining the ratio between the maximum achievable blood flow in a diseased coronary artery and the theoretical maximum flow in a normal coronary artery. An FFR of 1.0 is widely accepted as normal. An FFR lower than 0.75-0.80 is generally considered to be associated with myocardial ischemia (MI).

    Agreement between the method of measurement will be confirmed if both conditions are met:

    The mean paired difference is within +/- 0.005

Sponsors and collaborators

Lead sponsor

Boston Scientific Corporation

Industry

Registry information

Official study title

A Prospective, Multicenter Study to Evaluate the Performance and Safety of CometTM Pressure Guidewire in the Measurement of FFR in Chinese Patients

Important dates

Study start
2019
Primary completion
2020
Study completion
2020
First posted
Sep 23, 2019
Registry last updated
Nov 1, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.